Table 5.

Laboratory measures for patients who completed sodium thiosulfate or loratadine therapy.

Variable	Before treatment	After treatment	p
Serum sodium, mmol/L
Sodium thiosulfate group	139.14 ± 82.49	138.09 ± 73.18	0.54
Loratadine group	138.93 ± 69.22	139.72 ± 92.46	0.38
Serum potassium, mmol/L
Sodium thiosulfate group	4.16 ± 0.62	4.03 ± 0.70	0.68
Loratadine group	4.27 ± 0.74	4.36 ± 0.62	0.77
Serum calcium, mmol/L
Sodium thiosulfate group	2.12 ± 0.14	2.20 ± 0.20	0.73
Loratadine group	2.18 ± 0.31	2.22 ± 0.37	0.45
Serum phosphorus, mmol/L
Sodium thiosulfate group	2.01 ± 0.58	2.16 ± 0.39	0.96
Loratadine group	2.13 ± 0.46	2.21 ± 0.32	0.65
Parathyroid hormone, pg/ml
Sodium thiosulfate group	245.33 ± 143.27	239.23 ± 143.67	0.18
Loratadine group	261.31 ± 160.89	245.33 ± 143.27	0.09
Serum bicarbonate, mmol/L
Sodium thiosulfate group	20.88 ± 3.01	20.28 ± 3.22	0.46
Loratadine group	21.04 ± 4.15	20.53 ± 2.01	0.57
Serum anion gap, mmol/L
Sodium thiosulfate group	16.22 ± 3.21	16.81 ± 2.91	0.39
Loratadine group	15.94 ± 2.89	16.02 ± 6.39	0.17